2 assets in Developmental And Epileptic Encephalopathy, 14

Therapeutic assets addressing Developmental And Epileptic Encephalopathy, 14, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Abs-1230 Developmental And Epileptic Encephalopathy, 14	Actio Biosciences, Inc.	P2	B (60)
Omeprazole Developmental And Epileptic Encephalopathy, 14	Actio Biosciences, Inc.	P1	CC (43)